Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8966786 | 1.00 | MEN1 (0.44) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1874982 | 0.98 | TSHR (0.42) | MEN1KMT2ATHRBHTTMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL6990322 | 0.90 | TSHR (0.42) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL11126565 | 0.89 | TSHR (0.39) | TSHRGAATBXAS1ALDH1A1 | |
| SCHEMBL9062589 | 0.88 | MEN1 (0.48) | MEN1KMT2ATHRBHTTMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL8815476 | 0.85 | TSHR (0.46) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL585948 | 0.85 | TSHR (0.46) | MEN1KMT2ATHRBHTTMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL26090179 | 0.85 | TSHR (0.52) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL985177 | 0.82 | TSHR (0.43) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL33661 | 0.82 | THRB (0.44) | THRBTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9382434-B2 | Actinic radiation-curable inkjet ink and image forming method using same | Konica Minolta, Inc. (JP) | 2016-07-05 | — | — | US | claimed |
| EP-0716929-B1 | Ink-jet recording material having a polymer matrix coating | ARKWRIGHT INC (US) | 2000-04-19 | — | — | EP | claimed |
| US-9382434-B2 | Actinic radiation-curable inkjet ink and image forming method using same | Konica Minolta, Inc. (JP) | 2016-07-05 | — | — | US | disclosed |
| US-20130053506-A1 | FLUORINE COMPOUND AND ACTIVE ENERGY RAY-CURABLE RESIN COMPOSITION USING SAME | DIC CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
| EP-2115021-B1 | SOLID PHASE EXTRACTION OF AFLATOXINS | TOXIMET LTD (GB) | 2012-07-25 | — | — | EP | disclosed |
| EP-2134435-B1 | SOLID PHASE EXTRACTION OF OCHRATOXINS | TOXIMET LTD (GB) | 2010-08-25 | — | — | EP | disclosed |
| US-20100167409-A1 | SOLID PHASE EXTRACTION OF ALFATOXINS | TOXIMET LIMITED (GB) | 2010-07-01 | — | — | US | disclosed |
| US-20100151583-A1 | SOLID PHASE EXTRACTION OF OCHRATOXINS | TOXIMET LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| EP-2134435-A1 | SOLID PHASE EXTRACTION OF OCHRATOXINS | Toximet Limited (GB) | 2009-12-23 | — | — | EP | disclosed |
| EP-2115021-A1 | SOLID PHASE EXTRACTION OF AFLATOXINS | Toximet Limited (GB) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008125887-A1 | SOLID PHASE EXTRACTION OF OCHRATOXINS | TOXIMET LIMITED (GB) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008096179-A1 | SOLID PHASE EXTRACTION OF AFLATOXINS | TOXIMET LIMITED (GB) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053506-A1 | FLUORINE COMPOUND AND ACTIVE ENERGY RAY-CURABLE RESIN COMPOSITION USING SAME | RER1, AFF1, AFF4 | MEN1 3202/4885KMT2A 848/4885THRB 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.